Comparison of hematologic values and transforming growth factor-β and insulin-like growth factor concentrations in platelet concentrates obtained by use of buffy coat and apheresis methods from equine blood

American Journal of Veterinary Research

Volumn 65, Issue 7, 2004, Pages 924-930

  Sutter, Wesley W ^a   Kaneps, Andris J ^a,b   Bertone, Alicia L ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Parrott Equine Associates   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; SOMATOMEDIN C; THROMBOCYTE CONCENTRATE; THROMBOCYTE FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2;

ANIMAL CELL; APHERESIS; ARTICLE; BLOOD ANALYSIS; BLOOD SAMPLING; CELL FRACTIONATION; CLINICAL PROTOCOL; CONTROLLED STUDY; CORRELATION FUNCTION; FILTRATION; HORSE; INTERMETHOD COMPARISON; LEUKOCYTE COUNT; MALE; METHODOLOGY; NONHUMAN; RELIABILITY;

ANALYSIS OF VARIANCE; ANIMALS; BLOOD PLATELETS; HEMOFILTRATION; HORSES; LEUKOCYTE COUNT; PLATELET COUNT; PLATELETPHERESIS; SOMATOMEDINS; TRANSFORMING GROWTH FACTOR BETA;

ANIMALIA; EQUIDAE; EQUUS CABALLUS;

EID: 3442896276     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.2004.65.924     Document Type: Article

References (35)

1. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
2. Bennett SP, Griffiths GD, Schor AM, et al. Growth factors in the treatment of diabetic foot ulcers. Br J Surg 2003;90:133-146.
3. Steel CM, Robertson ID, Thomas J, et al. Effect of topical rh-TGF-beta 1 on second intention wound healing in horses. Aust Vet j 1999; 77:734-737.
4. Cross KJ, Mustoe TA. Growth factors in wound healing. Surg Clin North Am 2003;83:531-545.
5. Trengove NJ, Stacey MC, MacAuley S, et al. Analysis of the acute and chronic wound environments: the role of proteases and their inhibitors. Wound Repair Regen 1999;7:442-452.
6. Qiu B, Stefanos S, Ma J, et al. A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. Biomaterials 2003; 24:11-18.
7. Mierisch CM, Cohen SB, Jordan LC, et al. Transforming growth factor-beta in calcium alginate beads for the treatment of articular cartilage defects in the rabbit. Arthroscopy 2002;18:892-900.
8. Burdick JA, Mason MN, Hinman AD, et al. Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. J Control Release 2002;83:53-63.
9. Xu X, Yu H, Gao S, et al. Polyphosphoester microspheres for sustained release of biologically active nerve growth factor. Biomaterials 2002;23:3765-3772.
10. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-646.
11. Rendu F, Brohard-Bohn B. The platelet release reaction: granules' constituents, secretion and functions. Platelets 2001;12:261-273.
12. Moulin V. Growth factors in skin wound healing. Eur J Cell Biol 1995;68:1-7.
13. Zechner W, Tangl S, Tepper G, et al. Influence of platelet-rich plasma on osseous healing of dental implants: a histologic and histomorphometric study in Minipigs. Int j Oral Maxillofac Implants 2003; 18:15-22.
14. Kim S, Chung C, Kim Y, et al. Use of particulate dentin-plaster of Paris. combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants 2002;17:86-94.
15. Hom DB, Thatcher G, Tibesar R. Growth factor therapy to improve soft tissue healing. Facial Plast Surg 2002;18:42-52.
16. Carter CA, Jolly DG, Worden CE, et al. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003;74:244-255.
17. Sanchez AR, Sheridan PJ, Kupp LI. Is platelet-rich plasma the perfect enhancement factor? A current review. Int J Oral Maxillofac Implants 2003;18:93-103.
18. Silver F, Wang MC, Pins GD. Preparation and use of fibrin glue in surgery. Biomaterials 1995;16:891-903.
19. Yazawa M, Ogata H, Nakajima T, et al. Basic studies on the clinical applications of platelet-rich plasma. Cell Transplant 2003; 12:509-1518.
20. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg 2000;58:297-300; discussion 300-301.
21. Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants 2002; 17:184-190.
22. Wadhwa M, Seghatchian MJ, Lubenko A, et al. Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays. Br J Haematol 1996;93:225-234.
23. Weibrich G, Kleis WKG, Hafner G, et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Cursan kit, with preparations received from a local blood bank. Clin Oral Implants Res 2003; 14:357-362.
24. Weibrich G, Kleis WKG. Curasan PRP kit vs. PCCS PRP system collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma. Clin Oral Implants Res 2001; 13:437-443.
25. Weibrich G, Kleis WKG, Hafner G, et al. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002;30:97-102.
26. Appel TR, Potzsch B, Muller J, et al. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin Oral Implant Res 2001;13:522-528.
27. Vasconcelos E, Figueiredo AC, Seghatchian J. Quality of platelet concentrates derived by platelet rich plasma, buffy coat and apheresis. Transfus Apheresis Sci 2003;29:13-16.
28. O'Neill EM, Zalewski WM, Eaton LJ, et al. Autologous platelet-rich plasma isolated using the Haemonetics Cell Saver 5 and Haemonetic MCS+ for the preparation of platelet gel. Vox Sang 2001; 81:172-175.
29. Zimmermann R, Jakubietz R, Jakubietz M, et al. Different preparation methods to obtain platelet components as a source of growth factors for local application. Transfusion 2001; 41:1217-1224.
30. Weibrich G, Buch RS, Kleis WK, et al. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation. Growth Factors 2002;20:93-97.
31. Charan S, Palmer K, Chester P, et al. Transforming growth factor-beta induced by live or ultraviolet-inactivated equid herpes virus type-1 mediates immunosuppression in the horse. Immunology 1997; 90:586-591.
32. Furr M, Pontzer C. Transforming growth factor beta concentrations and interferon gamma responses in cerebrospinal fluid of horses with equine protozoal myeloencephalitis. Equine Vet J 2001;33:721-725.
33. Michelson AD. Platelets. San Diego: Academic Press Inc, 2002;880.
34. Weiss DJ, Evanson OA, McClenahan D, et al. Shear-induced platelet activation and platelet-neutrophil aggregate formation by equine platelets. Am J Vet Res 1998;59:1243-1246.
35. Karey KP, Sirbasku DA. Human platelet-derived mitogens. II. Subcellular localization of insulin like growth factor I to the alpha-granule and release in response to thrombin. Blood 1989;74:1093-1100.